RACHELLE JONES: Open Payments
NPI 1982830345 · REXBURG, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 32 payments from 6 companies in 2025. Trend: 2023 $460 · 2024 $537 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $287 |
| Lilly USA, LLC | 4 | $62 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Medtronic, Inc. | 1 | $15 |
Products named: QULIPTA, VRAYLAR, MOUNJARO, Auvelity, UBRELVY, AJOVY, LILETTA, FANAPT.
Industry payments across ID — which companies pay providers there.
